Category Archives: complex adaptive systems

Gruen: A unified economic theory of privately provided public goods and social capital

Nicholas delivers a terrific presentation (1hr 7mins) to The Australian Centre for Social Innovation about the private provision of public goods and the subsequent generation of social capital.

It is as crisply considered as it is thought provoking:

  • after all this time, I think I finally understand that economists believe themselves to be the purveyors and arbiters of well-being, and ultimately health – no wonder they’re so suspicious of, and have so much trouble relating to medicine and health care
  • it would be interesting to apply this prism to health care – I don’t think it will present favourably

The presentation wraps with a 5 min video of the Family by Family program – a compelling sounding intervention that generates an abundance of social capital by developing and then using resources embedded in the community.

Many references to Adam Smith, Hayek and Robert Putnam.

Great to see something not confined to the sub-20min constraint.

Bravo Nicholas!!


http://clubtroppo.com.au/2013/12/20/public-goods-privately-provided-the-video/

 

 

Dave Chase – How healthcare’s disruption will play out…

 

PDF Report: Volume_to_Value_Revolution

Healthcare’s Trillion-Dollar Disruption

As a healthtech startup, you can’t help but get excited when Bob Kocher (Venrock) or Esther Dyson speak about the opportunities in healthcare given their impressive track records. Both spoke during this past week’s StartUpHealth Summit.

One of Bob’s main points was that the opportunity in healthcare is so big that most startups are thinking too small and his firm is putting their money where his mouth is (e.g. Castlight). Esther has proven time and again to be very prescient — just go back and watch her old interviews on Charlie Rose over the years to see how accurately she predicts the future. She interrupted attending the JP Morgan presentations to visit with the StartUp Health Summit. Paraphrasing, she said companies like those in StartUp Health are the future. Rather than trying to steal share from the companies presenting at JP Morgan, startups should focus on creating the new market space, and the market will move to them…not the other way around.

Transformers vs. Preservatives

While the opportunities are massive, what’s the biggest obstacle to healthcare transformers? It’s the “preservatives” — the incumbent healthcare players. That is, the preservatives are trying to protect the status quo, rather than focusing on how to sincerely address the Triple Aim (improve outcomes, reduce cost, improve patient experience). In every healthcare organization I’ve talked with, whether they are a provider, pharma, or health plan, there are transformers internally who know what to do but are stymied by preservatives.

The same is true politically. There are those who call themselves “progressive” or “conservative.” Unfortunately, it seems that 80 percent of politicos are actually preservatives just doing the bidding of lobbyists trying to protect the status quo. The preservatives are costing thousands of lives and hundreds of billions of unnecessary wasted dollars. The real leaders in healthcare will see through them and get them out of the way of progress.

One of the transformative organizations pushing for change is Oliver Wyman. Oliver Wyman is a leading consultancy that has setup a Health Innovation Center that recently published a paper entitled The Volume-to-Value Revolution (PDF) with the input of an advisory board (PDF) of CEOs ranging from large public companies to emerging companies (disclosure: I’m on the Health Innovation Center Advisory Board). In that paper, authors Tom Main and Adrian Slywotzky make the case that new patient-centered population health models will cause more than $1 trillion of value to rotate from the old models to the new and create more than a dozen new $10 billion high-growth markets (see also Patients Are More Than A Vessel For Billing Codes). Each of these markets creates large opportunities for healthtech startups. Naturally, legacy vendors are optimized for the old models (see Why It’s Good News HealthIT is So Bad) while startups optimize for the new models.

Most industries compete on value. U.S. healthcare does not. But that is about to change.

Healthcare innovators are already redefining healthcare value, putting patients first and inventing with little regard for current constraints. They have ignited a powerful, self-funding upward spiral by focusing first on healthcare’s big opportunities, transforming the value equation, generating large savings, and fueling smart reinvestment in the next wave of innovation. [Introduction, “The Volume-to-Value Revolution”]

In addition, the necessity for change and the accompanying opportunities are causing many healthcare incumbents to establish venture arms. See Strategic Healthcare Investors’ Investment Thesis for more.

Industry Boundaries Rapidly Crumbling

Everyone is getting into each other’s and new businesses. Industry incumbents would be well advised to learn from the mistakes of incumbents in other disrupted sectors. As I observed earlier, providers are making newspaper industry mistakes.

The changes the industry faces will be neither smooth nor linear. A period of intense turbulence will produce more losers and winners than any industry transformation in recent memory. Cross-industry competition (healthcare versus retail versus technology versus others) will erase traditional boundaries and generate exciting new value propositions for patients, payers, and physicians.

For example, just this past week, Walgreen‘s has made it clear they’ll compete with healthcare providers and insurance companies. Competition, as newspapers learned, doesn’t come from obvious places.

Consumerization Of Healthcare

The consumer empowerment taken for granted from everything from buying cars to planning travel is finally arriving in healthcare nearly 15 years later than most industries.

Consumers, long passive, will have a new role. Employer incentives, retail access, and new technology options will encourage them to engage, demand information, and push for value. Baby boomers reaching the age of peak healthcare need will kindle the fire and Millennials focused on nutrition and fitness will keep it burning. The industry’s metamorphosis from a supply-driven market to a more dynamic one driven by demand will happen more quickly and erratically than we expect. Inevitably, mental models will lag behind market reality, and conventional organizations will fight a rearguard battle, hampered by collapsing margins and eroding market share.  [Introduction, “The Volume-to-Value Revolution”]

Walmart recently validated the domestic medical tourism I wrote about awhile back. Their Centers of Excellence program encourages their insured employees to go to the top facilities in the country for free (including travel expenses). The employees have to pay if they choose to go with organizations that haven’t demonstrated a willingness to have a fixed price while producing some of the best outcomes in the world. Love them or hate them, Walmart has a huge ripple effect. Overnight, every facility in America that does cardiac, spinal, or transplant procedures is now competing with Mayo, Cleveland Clinic and other top providers. Sticking to old models and tools endangers the traditional healthcare player.

By 2014, as many as 85 million consumers with $600 billion in purchasing power may be shopping for their own healthcare on public and private exchanges. Many will be making their own decisions about coverage for the first time. Consumers will shop not just for insurance, but also for their preferred population-health manager and standalone services, such as basic procedures and retail clinics. [pg. 18, “The Volume-to-Value Revolution”]

New Models Jeopardize Hospitals

Many are predicting half of hospitals will close by 2020. In Denmark, nearly 70 percent of hospitals closed as they made the shift from a reactive, sick-care model to proactive care model. More clinicians than ever will be needed. They’ll simply have a mainframe-to-smartphone like shift as outlined inhealthcare’s age of agility. Unfortunately, the average hospital is one of the most dangerous places with over 100,000 hospital-acquired infections causing death every year. Hospitals are almost always the most expensive place to deliver care so smart health systems are developing new models with a fresh start — what I call the Xboxification of Healthcare.

One of the reasons providers are choosing cloud-based systems over on-premise software is the resource-intensive deployments required with legacy systems. We’ve seen a small clinic get their cloud-based system fully setup and ready to use in 30 minutes without any onsite people. In contrast,  in that same amount of time, one might be able to order the server that gets shipped to that clinic. They will then require onsite installers, trainers, etc. and have a dramatically higher cost base to run that system.

For entirely rational reasons, those older systems were optimized for internal workflows and maximizing billing since that is what has been rewarded historically. To think that those traditional systems will then work perfectly well in the ascending “No Outcome, No Income” era borders on delusional. The reality is hitting right away. A recent article in a HIMSS publication quoted a leading thinker in healthIT, Shahid Shah, outlining 9 major gaps in existing EHRs. He listed “sophisticated patient relationship management (PRM)” as the first major gap. It’s my opinion that as integral as EHRs have been to fee-for-service, PRM will be to fee-for-value. The old model relegated patient portal functionality to be little more than a marketing checkbox. In the new model, PRM functionality becomes a linchpin. In other words, patient portals have been like pre-Google web search (low value afterthoughts on web portals). As Google demonstrated, with the right circumstances, there was huge value ignored by the established players. Likewise, if PRM is viewed as an afterthought, that will increase the risk to providers during this transformative period. Being flat-footed in a time of great change is extremely risky.

The New York Times reported this past week that the public hospitals are already changing the way they compensate their doctors. The first performance measure they listed was how well patients say their doctors communicate with them. These doctors are used to easy communication in the rest of their life with email, text, Facebook, etc.  Suddenly, the hospital IT departments are going to start hearing from doctors asking why they can’t have tools that are as easy to communicate with their patients in the other areas of their life. It’s a rare occurrence to hear a doctor say how user-friendly and patient-focused their EHR is. Of course, it’s about more than just technology. The technology simply enables new models. Despite many doctors’ fears, often the changes are for the better as was mentioned by Dr. Bob Margolis, founder and CEO of HealthCare Partners, and one of the physician leaders who has demonstrated extraordinary outcomes:

You get to the tipping point, where the physicians go, ‘Wow, life is a whole lot better.’ You know, I only have to see 20 patients a day and I go home at night and I feel like I really helped them’—as opposed to, ‘I saw 45 patients, worked until 10 o’clock because I had to then do all my paperwork, I’m tired and I can barely pay the bills because Medicare and the commercial insurers are cutting back on my reimbursement.’

Oliver Wyman’s report projects that patient-centered care and the shift to value will eliminate $500 billion in low-value-add activities. One has to be in major denial as a healthcare leader to think that we aren’t entering a deflationary era in healthcare. Just watch Bill Gates’ TED Talk on state budgets if you have any doubts. This is exactly the reason the state of New York has moved aggressively to change care and payment models. While doing that, they recognized new models require new technology and didn’t expect they’d get it from legacy providers. This is why the New York Digital Health Accelerator was established. The good news for proactive health systems is that one can thrive in a deflationary period if they shed old assumptions.

A leader at Virginia Mason in Seattle shared how Starbuck’s pushback on costs caused them to look at their entire care proces:

 “90 percent of what the hospital was doing was of no value.” As it turns out, the best way to treat most back pain is with physical therapy. That insight led to new processes, including same-day visits (as opposed to 31-day waits), reduced use of imaging tests and prescription drugs, and the addition of psychological support. Within three months, 94 percent of Starbucks employees with back-pain complaints were back at work within a day.

Even today, many EMR vendors will justify the price tags that reach into the hundreds of millions of dollars on the basis of increased billings. That game is nearly over and those hospitals will be saddled with systems optimized for the old models. This past week there were articles in the New York Times and Washington Post stating that EHRs have “failed”. I’d dispute that. EHRs have done exactly as they were designed — maximize billings. That’s how they are pitched so it should be no surprise that costs haven’t been lowered.

It has been said that “when the rate of change outside exceeds the rate of change inside, the end is in sight.”

Three Waves Of Disruption

Below, I have excerpted and paraphrased some more of Oliver Wyman’s insights from the Volume-to-Value paper illustrating how each of the three anticipated waves of disruption will shift hundreds of billions of revenue from one set of players to another:

Wave 1: Patient-Centered Care (2010-2016). “If we simply mainstreamed today’s best-in-class models of patient-centered, population-health management, the U.S. health system would eliminate nearly $350 billion of low-value-add activity and shift another $600 billion from provider-centered care models to patient-centered care models.” […] ”Five percent of Americans account for 45 percent of healthcare spending—$1.2 trillion. These 15 million unhealthy Americans at the top of the healthcare pyramid are at the heart of the near-term healthcare affordability crisis and the unfortunate victims of our fragmented, illness- focused healthcare system.” [pages 5 and 7, “The Volume-to-Value Revolution”]

 

Cost & population pyramid

Wave 2: Consumer Engagement (2014-2020). In Wave 2, another $150 billion in low-value-add activities is squeezed out, while $400 billion of additional value will rotate to the new retail value chain.

Oliver Wyman transition


Wave 3: The Science Of Prevention (2018-2025). Wave 2 will help Wave 1’s great population managers become even more effective and will devastate provider-centric players who have lagged the market. Wave 3 will make the most highly evolved and adaptive population health managers more powerful and will significantly constrict the Wave 1 players who don’t continue to accelerate innovation.

Big Opportunities Require Big Brains

I once heard someone say, “There’s a lot of big brains working on small problems.” They were commenting on the brainpower working on the 8,000th social media app versus where they should be applying their brains. That is, there are three areas that demand as many big brains as possible — healthcare, education, and energy. As a skier, I often say that healthtech startups are the double black diamond in whiteout conditions of startups: super challenging and exhilarating but not for the faint of heart.

I believe the trick is to understand the idiosyncrasies of healthcare without being shackled by them. If you want to make a difference, there’s no better place than healthcare. Healthcare needs all the engineering talent possible that is often wasted on low-impact areas of the tech industry.

Follow @chasedave on Twitter or request the Care Beyond the Clinic newsletter for ongoing updates on healthcare innovation and disruption.

Antifragile – Taleb at the RSA

This hour long presentation covers the key points from Taleb’s Antifragile. It doesn’t matter how often I read or listen to this, it still comes across as massive. Interesting that the UK conservatives are taking it up with vigor, hmm….

Big Ideas page: http://www.abc.net.au/radionational/programs/bigideas/antifragile/4501692

RSA page: http://www.thersa.org/events/audio-and-past-events/2012/antifragile

Full RSA audio link

Antifragile

Tuesday 12 February 2013 8:05PM

 

In 2006 Nassim Taleb came to prominence with the publication of The Black Swanand the idea that the world is full of highly improbably and unpredictable events. In his latest book Antifragile he explains how to live with, and respond to, these seemingly random and unforeseen black swan events.

The key he says is to create systems that are Antifragile; ones that are not simply robust or resilient but can adapt and improve when subjected to uncertainty, chaos and volatility.

Highlights of Antifragile – RSA (UK) 6th Dec. 2012

Guests

Nassim Taleb
Distinguished Professor of Risk Engineering at New York University’s Polytechnic Institute.
Author of ‘Antifragile: how to live in a world we don’t understand’ (Allen Lane, 2012).
Rohan Silva
Senior policy adviser to UK Prime Minister, David Cameron.
Fraser Nelson
Editor, The Spectator (UK)

Further Information

The RSA

Credits

Presenter
Paul Barclay
Abridger
Ian Coombe

emulin food additive addresses metabolic impact of junk food

  • who needs a healthy diet when you can fortify it with metabolic sensitizers? Mubadala does, and they want to put it in the food supply.
  • “It addresses the metabolic impact of both the milkshake you’re drinking and the cheeseburger you’re having with it”
  • It impacts on the glycaemic and metabolic impact of ingested junk foods by 30%
  • it apparently works acutely and chronically
  • it sounds like snake oil.. I hope Marc has run an interpol check on these guys
  • http://www.foodnavigator-usa.com/content/view/print/837344

Glucose management ingredient gets UAE distribution, ‘needs to be in food supply,’ founder says

By Maggie Hennessy, 25-Oct-2013

Related topics: Suppliers, Markets

Sometimes the best way to build a new market is to step back.

This is the case for ATM Metabolics, whose cofounders Dr. Daryl Thompson and Dr. Joseph Ahrens created Emulin, a patented blend of plant-sourced chlorogenic acid, myricetin and quercetin that claims to help maintain healthy blood sugar levels and facilitate weight loss in diabetics.

Facing hesitation from American corporations about incorporating Emulin into foods, the company has signed a licensing deal with United Arab Emirates development company Mubadala to distribute Emulin as both a medical food and as an additive to fortify diabetically sensitive food products. The firm hopes the distribution and resulting“dramatic improvement in glycemic management for type 2 diabetics,” who make up a growing percentage of the population in the UAE, will be a springboard to deploying Emulin as a medical food in the US.

“We need this to be in the food supply,” Thompson told FoodNavigator-USA. Emulin is currently available in the US as Diabetix, a dietary supplement supplied by VREV.

Blocks GI of the ‘whole meal’

Developed by ATM Metabolics cofounders Dr. Daryl Thompson and Dr. Joseph Ahrens, Emulin works by interrupting the metabolic pathways of carbohydrate metabolism. It claims to reduce glucose synthesis in the liver, enhance glucose uptake from the bloodstream, and increase the sensitivity of insulin receptors in the signaling pathways—thereby making insulin more efficient, according to Thompson.

What makes it so important for Emulin to be incorporated into food, he added, is it will not only block the glycemic impact of what you’re eating and drinking, but the whole meal. In other words, it addresses the glycemic impact of both the milkshake you’re drinking and the cheeseburger you’re having with it.

“Emulin when added to foods had the ability to reduce the entire glycemic impact and caloric impact of a whole meal by up to 30%,” he said. “This is because Emulin actually inhibits or ‘puts to sleep’ the enzymes in the body that are responsible for breaking down, transporting and storing sugars while inducing activity in metabolically useful enzymatics such as those in muscle tissue. Emulin reduces the amount of sugars that the body absorbs and at the same time enhances the body’s ability to utilize the sugars instead of storing them as fat.

“The good thing about this is that it is a ‘chaperone’ process that was developed by nature to properly regulate sugar transportation and usage in the human body. Our research team was lucky enough to identify this process and learn how to adapt it to our processed foods to make them safer glycemically.”

Thompson claims that Emulin works at both the acute and chronic level, meaning “the longer you take it, the less diabetic you become.”

Reeducating corporate America on ‘disruptive technology’       

The primary motivators for taking Emulin to the UAE were twofold: the growing incidence of diabetes in the UAE and the hesitance of American food companies to embrace new, disruptive technology in the diabetes realm.

The UAE has experienced remarkable economic growth in a relatively short period of time, which has raised the prosperity of its population. But this new-found wealth has also brought with it a growing incidence of metabolic syndrome and diabetes. According to the World Health Organization and International Diabetes Federation, 32% of the adult UAE population (age 20-79) may have diabetes or pre-diabetes, with other data indicating that the adult UAE population (ages 18 and above) has already reached a diabetes or pre-diabetes rate of 44%.

“The UAE is rife with diabetes and metabolic syndrome, but it also has a very forward-thinking healthcare system. And they’ve shown they really want to address this growing problem,” Thompson said. “We’re developing a plan there to get this distributed throughout the country and use it as model of how we will model foods here.”

The second reason for crossing the pond is the resistance of American food companies to embrace  “We’ve met with every American food company out there and the story is the same: they’ve gotten too big to be able to properly handle new disruptive technology,” he said. Thus, by spearheading the effort in the UAE, ATM Metabolics can demonstrate the practical approaches to dealing with metabolic diseases like diabetes with physical evidence. The product will be rolled out in the next six months, and Thompson expects to bring it back to the US within a year.

“We are working diligently to use UAE as a showcase to show how diabetes can be rapidly treated using Emulin in the food supply,” he said. “We’re hoping that this will serve as a blueprint for reeducating corporations here in the US.”

Human evolutionary biology and mismatch diseases

  • Book: The Story of the Human Body: Evolution, Health and Disease
  • Questions our culture’s overwhelming focus on treatment of symptoms instead of prevention
  • We’re adapted to put on fat, not lose it. We’re adapted to be physically active, not inactive

Type 2 diabetes a ‘mismatch disease’ for our Paleolithic bodies

21-Oct-2013

When we examine the long list of noninfectious diseases that trouble modern society—which run the gamut in severity from flat feet to acid reflux, anxiety, certain cancers, high blood pressure, obesity and type 2 diabetes—it helps to look back, way back, to the root causes to find answers, said Daniel Lieberman, chair of the Department of Human Evolutionary Biology at Harvard University.

Sir Muir Gray – ACSQHC Presentation

  • We’re entering a new era in the NHS where there is “NO MORE MONEY

@19min: describes “three big businesses in respiratory disease – asthma, COPD, apnoea”

  • Value = Outcomes / Costs
  • Outcome = Effectiveness (EBM+Quality) – Harm (Safety)
  • Costs = Money + Time + Carbon

@22mins: moving from guideline care to personalised care

@26mins: Bureaucracy is important and necessary, but should stick to what it’s good at doing:

  1. The fair and open employment and promotion of people
  2. The un-corrupt management of money
  3. !! Not the curing of disease or delivery of health care – populations defined by need, not jurisdiction

@32mins: law of diminishing returns – benefits plateau as invested resources rise

@33mins: Harmful effects of healthcare increase in direct proportion to the resources invested

@34mins: combine the 2 curves – get a j-shaped curve with a point of optimality – the point of investment after which, the health gain may start to decline

@35mins: as the rate of intervention in the population increases, the balance of benefit and harm also changes for the individual patient

@37mins: value spectrum

[HIGH VALUE]
– necessary
– appropriate
[LOW VALUE]
– inappropriate
– futile
[NEGATIVE VALUE]

@39mins: The Payers’ Archipelago

20th Century Care >> 21st Century Care
Doctor >> Patient
Bureaucracy >> Network
Institutions >> Systems

@42mins: clinicians responsible for whole populations, not just the patients in front of them

@45mins: How to start a revolution
– change the culture – destabilise and constrain; control language
– engage patients and citizens, and the future leaders of 2033
– structure doesn’t matter (5%)
– systems (40%)
– culture or mindset (50%)

@46mins: Culture – the shared tacit assumptions of a group that it has learned in coping with external threats and dealing with internal relationships” Schein (1999) The Corporate Culture Survival Guide

@47mins50s: data doesn’t change the world, emotion changes the world
– atlases written for OMG effect
– programme budgeting

destabilise then constrain then change the language

@49mins: MUDA means waste — resource consumption that doesn’t contribute to the outcome. motonai – the feeling of regret that resources are being wasted. ban old language.

@51mins: mandatory training in new thinking

The Third Healthcare Revolution is already underway
1. PHONE
2. CITIZENS
3. KNOWLEDGE

The third healthcare revolution will come out of the barrel of a smartphone

@56mins: Healthcare is too complex to be run by bureaucracies or markets. Work like an ant colony – neither markets nor bureaucracies can solve the challenges of complexity.

 

PDF: Sir-Muir-Gray-Masterclass-presentation-1-Oct-2013

ASQHC Presentation link: http://www.safetyandquality.gov.au/our-work/medical-practice-variation/presentations/

Forcing the prevention industry – a 10 year journey

Vision

  • The Future of Human API www.thehumanapi.com
  • Forcing the prevention industry into existence
  • Stage Zero disease detection and treatment

Critical trends:

  • lab-in-a-box diagnostics
  • quantified self
  • medical printing

When these trends converge, there’ll be an inflection point where a market is established.

Health data moves from system of record >> system of engagement.

Promoting the evolution from a Product mentality to a Market mentality

As treatment starts to focus on Stage Zero/pre-clinical disease,  it turns into prevention.

 

Video: http://www.youtube.com/watch?feature=player_embedded&v=gJHaoqeucX8

http://www.forbes.com/sites/johnnosta/2013/12/12/the-asymptotic-shift-from-disease-to-prevention-thoughts-for-digital-health

The Asymptotic Shift From Disease To Prevention–Thoughts For Digital Health

It’s been said that good artists borrow and great artist steal.  And I believe that Picasso was right.  So, I guess I’m somewhere between a thief and a artist and that suits me just fine.

I’ve stolen from two great thinkers, so let’s get that out of the way.  The first isDaniel Kraft, MD. Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. He’s the founded and Executive Director of FutureMed, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. He’s also a go-to source on digital health. I’m stealing “zero stage disease” from Dr. Kraft. Simply put, it’s the concept of disease at its most early, sub-clinical stage.  It’s a point where interventions can halt or change a process and potentially eliminate any significant manifestation of disease.

The second source of inspiration is Richie Etwaru.  He is a brilliant and compelling speaker and a champion for global innovation, Mr. Etwaru, is responsible for defining and delivering the global next generation enterprise product suite for health and life sciences at Cegedim RelationshipManagement. His inspiring video, The Future of Human API really got me thinking.

At the heart of Mr. Etwaru’s discussion is the emergence of prevention–not treatment–as the “next big thing”.

EtwaruSlide

Ok, nothing new so far.  But the important changes seen in the digital health movement have given us a profound opportunity to move away from the conventional clinical identification of a that golf-ball sized tumor in your chest to a much more sophisticated and subtle observation. We are beginning to find a new disease stage–different from the numbers and letters seen in cancer staging.  The disease stage is getting closer and closer to zero.  It’s taking an asymptotic path that connects disease with prevention. The point here is that the holy grail of prevention isn’t born of health and wellness.  Prevention is born out of disease and our new-found ability to find it by looking closer and earlier.  Think quantified self and Google Calico.

And here lies the magic.

We all live in the era of disease.  And the vast majority of healthcare costs are spent after something happens. The simple reality is that prevention is difficult to fund and the health-economic model is so skewed to sickness and the end of life that it’s almost impossible to change. But if we can treat illness earlier and earlier–the concept of an asymptote–we build a model where prevention and disease share the very same border.  They become, in essence, the same. And it’s here that early, early, early disease stage recognition (Stage Zero) becomes prevention. The combination of passive (sensor mediated) observation and proactive life-style strategies for disease suppression can define a new era of health and wellness.

Keep Critical! Follow me on Twitter and stay healthy!

 

NeuroOn sleep tracking mask…

Polyphasic sleep looks like something I want to get into, though am not convinced this is the way to achieve it. Will see how the trials go….

http://www.kickstarter.com/projects/intelclinic/neuroon-worlds-first-sleep-mask-for-polyphasic-sle

The NeuroOn is for you!

The final prototype
The final prototype

What is polyphasic sleep?

It is a term referring to alternate sleep patterns that can reduce the required sleep time to just 2-6 hours daily. It involves breaking up your sleep into smaller parts throughout the day, which allows you to sleep less but feel as refreshed as if you slept for 8 hours or more.

Polyphasic sleep modes
Polyphasic sleep modes

Simply put, it’s a series of fine-tuned power naps that allow you to sleep effectively, rest better and perform at optimum energy levels during the day.

Additionally, NeuroOn monitored polyphasic sleep allows you to sync your body clock to very demanding schedules at whatever time is convenient or required.

In conclusion, through great sleep efficiency, Polyphasic sleep can give you an extra 4 hours of free time every day. That’s up to 28 hours (1 day+) a week, 1460 hours a year.

That’s right – Your year now has over 420 working days!

Trust the masters

So, you’ve heard of Leonardo? No, not the turtle!

Apparently Da Vinci, Tesla, Churchill and even Napoleon used polyphasic sleep to rest. It allowed them to fully regenerate, reducing sleep time to 6.5 hours or sometimes just 2 hours. And those guys got things done!

Famous polyphasic sleepers
Famous polyphasic sleepers

Prevention Economics

Right. So I’m now comfortable with the idea that the greatest failing of modern healthcare is for it to have extended lifespan without having extended healthy life years. The challenge then, is to extend fully productive life to something far closer to our life expectancy. This can be done with a plant based diet, fasting and moderate exercise. No pills. No fads. Jus a new norm.

But how do we pay for it? Determine the economic cost of extending a life’s productivity by a year seems like a reasonable first step. Then take a piece of that?

Bring in the direct beneficiaries of such a change – the life insurers, super funds and broccoli farmers.

What a great bunch of business partners they’d be.

Giddy up….